In practice, a well-formulated serum in the 0.1-1% range with good stability performs strongly because the molecule is active at very low levels
Semin Cell
This interaction is also evident in case studies, where most reported toxicities occurred when kratom was taken with other drugs
Measuring your nutritional status is important for many chronic conditions and even just for general health
WC Hop, BC Opmeer, JB Reitsma, RA Scholte, EWH Waltmann, A Legemate,, JF Bartelsman, DW Meijer, M de Brouwer, J van Dalen, M Durbridge, M Geerdink, GJ Ilbrink, S Mehmedovic, P Middelhoek, MJ Boom, ECJ Consten, JDW van der Bilt, GDJ van Olden, MAW Stam, MS Verweij, Sandra Vennix, Gijsbert D Musters, Hilko A Swank, Marja A Boermeester, ORC Busch, CJ Buskens, Y El-Massoudi, AB Kluit, CC van Rossem, MP Schijven, PJ Tanis, C Unlu, Susan van Dieren, MF Gerhards, TM Karsten, LC de Nes, H Rijna, BA van Wagensveld, G I Koff eman, EP Steller, JB Tuynman, SC Bruin, DL van der Peet, CFJM Blanken-Peeters, HA Cense, E Jutte, RMPH Crolla, GP van der Schelling, M van Zeeland, EJR de Graaf, RPR Groenendijk, TM Karsten, M Vermaas, O Schouten, MR de Vries, HA Prins, DJ Lips, RJI Bosker, J A B van der Hoeven, J Diks, PW Plaisier, PM Kruyt, C Sietses, MWJ Stommel, SW Nienhuijs, IHJT de Hingh, MDP Luyer, G van Montfort, EH Ponten, JF Smulders, EB van Duyn, JM Klaase, DJ Swank, RT Ottow, HBAC Stockmann, J Vermeulen, RJCL M Vuylsteke, HJ Belgers, S Fransen, EM von Meijenfeldt, MN Sosef, AAW van Geloven, ER Hendriks, B ter Horst, MMN Leeuwenburgh, O van Ruler, JM Vogten, EJC Vriens, M Westerterp, QAJ Eijsbouts, A Bentohami, TS Bijlsma, N de Korte, D Nio, MJPM Govaert, J JA Joosten, RAEM Tollenaar, L P S Stassen, M J Wiezer, EJ Hazebroek, AB Smits, HL van Westreenen, JF Lange, A Brandt, WN Nijboer, Irene M Mulder, BR Toorenvliet, WF Weidema, PPLO Coene, GHH Mannaerts, D den Hartog, RJ de Vos, JF Zengerink, AGM Hoofwijk, K W E Hulsew, J Melenhorst, JHMB Stoot, WH Steup, PJ Huijstee, JWS Merkus, JJ Wever, JK Maring, J Heisterkamp, WMU van Grevenstein, MR Vriens, MGH Besselink, IHM Borel Rinkes, AJ Witkamp, GD Slooter, JLM Konsten, AF Engel, EGJM Pierik, TG Frakking, D van Geldere, GA Patijn, BelgiumAJL DHoore, A de Buck van Overstraeten, M Miserez, I Terrasson, A Wolthuis, S di Saverio, MG de Blasiis Funding The initial ladies trial and 12-month follow-up period was funded by Netherlands Organisation for Health Research and Development (ZonMw)
